:

Surgical Oncology > HeadBreastSection


John P  Murtha Cancer Center Logo


Jeffery T. Lenert, MD, FACS
Captain, Medical Corps, US Navy
Assistant Professor of Surgery, Uniformed Services University, Bethesda, MD
Head, Breast Section, Division of General Surgery, WRNMMC, Bethesda, MD


COL Craig D. Shriver, FACSExpertise
Pancreatic Cancer, Whipple Procedure, Colon Cancer Liver Metastases, Gallbladder Cancer, Liver Resection, Gastric Cancer, Neuroendocrine tumors (Gastroenteropancreatic), Gastrointestinal Cancers, Breast Cancer, Thyroid Cancer, Hyperparathyroidism, Colorectal Cancer, General Surgery, Retroperitoneal Sarcomas, Sarcoma, Melanoma

Education
  • Bachelor of Arts (1983), University of Virginia (Charlottesville, VA)
  • Doctor of Medicine (1989), Baylor College of Medicine (Houston, TX)
  • Master of Business Administration (2001), University of Houston (Houston, TX)
Residency
  • General Surgery (1995), University of Pittsburgh Hospitals (Pittsburgh, PA)
Fellowship
  • Clinical Research Surgical Oncology (1993), Memorial Sloan-Kettering Cancer Center (New York, NY)
  • Surgical Oncology (2001), University of Texas, MD Anderson Cancer Center (Houston, TX)
Certifications
  • Surgery, American Board of Surgery (1996)
  • Surgical Oncology, Society of Surgical Oncology (2002)
Bio
Dr. Lenert is a native of Annandale, VA. He graduated with High Distinction from the University of Virginia in Charlottesville, VA in 1983 where his academic achievement granted him membership into the Phi Beta Kappa Academic Honor Society. In 1989, he graduated with Honors from Baylor College of Medicine in Houston, TX and was awarded membership into the Alpha Omega Alpha Honor Medical Society. He completed his residency training in General Surgery in 1995 at the University of Pittsburgh Hospitals with one year spent at Memorial Sloan-Kettering Cancer Center in New York participating in laboratory and clinical oncology research. Upon completing his General Surgery training Dr. Lenert was assigned as General Surgeon to Fleet Surgical Team One deploying aboard USS ESSEX (LHD-2) and USS PELELIU (LHA-5) to the Arabian Gulf.

He completed training in Surgical Oncology at the University of Texas, MD Anderson Cancer Center in Houston, TX in 2001 while also completing his MBA at the University of Houston. He has been a surgical oncologist since 2001 and has practiced at the National Naval Medical Center, Bethesda until its merger with Walter Reed Army Medical Center in 2011. He is proud to be a “plank owner” at the new Walter Reed National Military Medical Center. He is a Fellow of the American College of Surgeons and is a member of the Society of Surgical Oncology.

Dr. Lenert has deployed on USNS Comfort (T-AH-20) in March 2003 in support of Operation Iraqi Freedom as well as with Expeditionary Medical Facility Kuwait, Camp Arifjan, Kuwait in 2006. He served as Officer-in-Charge of a Navy Forward Surgical Element deployed to Afghanistan in support of Operation Enduring Freedom with the US Army; Combined Joint Special Operations Task Force in 2010. Additional duty has included deployments aboard USS KITTY HAWK (CV-63), USS ENTERPISE (CVN-65) and to USNH Keflavik, Iceland.

Selected Publications
  1. Fogelson MH, Craig WD, McPhee JR, Lenert JT, Henry LR. Glenohumeral Joint Ganglion Cyst – and Other rare Cysts of the Axilla. Am Surg. 2007 Sep;73(9):909-11.
  2. Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 1;94(1):197-204.
  3. Lenert JT, Barnett CC Jr, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA, Evans DB, Lee JE. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery. 2001 Dec;130(6):1060-7.
  4. Baker TP, Lenert JT, Parker J, Kemp B, Kushwaha A, Evans G, Hunt KK. Lactating adenoma: a diagnosis of exclusion. Breast J. 2001 Sep-Oct;7(5):354-7.
  5. Vlastos G, Fornage BD, Mirza NQ, Bedi D, Lenert JT, Winchester DJ, Tolley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Buzdar AU, Singletary SE. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg. 2000 Jun;179(6):446-52.
  6. Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, Ross MI, Buzdar AU, Singletary SE. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer. 2000 Mar 15;88(6):1417-24.
  7. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Strom E, Buzdar AU, Hortobagyi GN, Singletary SE. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol. 1999 Dec;6(8):762-7.
  8. Tarman GJ, Lenert JT, Hall L, Kane CJ. Holmium:YAG laser lithotripsy of intrahepatic biliary calculi. J Endourol. 1999 Jun;13(5):381-3.
  9. Port JL, Ng B, Ellis JL, Nawata S, Lenert JT, Burt ME. Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survival. Ann Thorac Surg. 1996 Sep;62(3):848-52.
  10. Ng B, Lenert JT, Weksler B, Burt ME. Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors. Ann Thorac Surg. 1995 Sep;60(3):624-9.
  11. Ng B, Lenert JT, Weksler B, Port JL, Ellis JL, Burt ME. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Ann Thorac Surg. 1995 Jan;59(1):205-8.
  12. Weksler B, Blumberg D, Lenert JT, Ng B, Fong Y, Burt ME. Isolated single-lung perfusion with TNF-alpha in a rat sarcoma lung metastases model. Ann Thorac Surg. 1994 Aug;58(2):328-31; discussion 332.
  13. Weksler B, Ng B, Lenert J, Burt M. A simplified method for endotracheal intubation in the rat. J Appl Physiol. 1994 Apr;76(4):1823-5.
  14. Weksler B, Lenert JT, Ng B, Burt ME. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg. 1994 Jan;107(1):50-4.
  15. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg. 1993 Aug;56(2):209-14.